DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
Montrouge, France, February 27, 2023
DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Thursday, March 2, at 5:00 p.m. ET to report full year 2022 financial results and provide a business update.
Interested participants may access this call via the below teleconferencing numbers and asking to join the DBV Technologies call:
- United States: 1-866-777-2509
- International: 1-412-317-5413
A live webcast of the call will be available on the Investors & Media section of the Company’s website: https://www.dbv-technologies.com/investor-relations/. A replay of the presentation will also be available on DBV’s website after the event.
About DBV Technologies
DBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT™, and is DBV Technologies’ method of delivering biologically active compounds to the immune system through intact skin. With this new class of non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients. DBV Technologies’ food allergies programs include ongoing clinical trials of Viaskin Peanut. DBV Technologies has global headquarters in Montrouge, France, and North American operations in Basking Ridge, NJ. The Company’s ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345) and the Company’s ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).
Investor Contact
Anne Pollak
DBV Technologies
+1 857-529-2363
anne.pollak@dbv-technologies.com
Media Contact
Angela Marcucci
DBV Technologies
+1 646-842-2393
angela.marcucci@dbv-technologies.com
Viaskin and EPIT are trademarks of DBV Technologies.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Amendment of Articles of Association25.4.2024 17:06:14 CEST | Press release
Company announcement no. 13/2024 With reference to release no. 12/2024 of 25 April 2024, changes in Columbus A/S’ Articles of Association as a consequence of the decision made by the Annual General meeting to amend the authorizations in Art. 5.1, 5.4 and 8.2 have today been registered in the Danish Business Authority. New Articles of Association are attached. Ib Kunøe Søren Krogh Knudsen Chairman of the Board CEO & President For further information, please contact: CEO & President, Søren Krogh Knudsen, +45 70 20 50 00 Attachment Articles of Association 250424
Vedtægtsændringer25.4.2024 17:06:14 CEST | pressemeddelelse
Selskabsmeddelelse nr. 13/2024 Der henvises til meddelelse nr. 12/2024 af 25. april 2024. Ændringerne i Columbus A/S’ vedtægter som følge af generalforsamlingens beslutning om at udvide bemyndigelserne i pkt. 5.1, 5.4 og 8.2 er d.d. registreret i Erhvervsstyrelsen. Der vedhæftes nye vedtægter. Ib Kunøe Søren Krogh Knudsen Bestyrelsesformand Koncernchef Kontakt for yderligere information: Koncernchef, Søren Krogh Knudsen, tlf.: +45 70 20 50 00 Vedhæftet fil Vedtægter 250424
Teledyne FLIR IIS expands its Forge camera series with IP67 rating targeting smart agriculture, food, and beverage industries25.4.2024 17:00:00 CEST | Press release
The Forge 1GigE IP67 camera series is designed for reliability in demanding industrial factory automation environments RICHMOND, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Teledyne FLIR IIS is pleased to announce the Forge® 1GigE IP67, the latest in its industrial camera series designed to perform in harsh industrial environments while ensuring highly efficient production capabilities. Forge 1GigE IP67 is the latest in our commitment to deliver advanced imaging systems for factory automation. “We are proud to announce the launch of our latest machine vision product, exclusively designed for smart agriculture, food, and beverage industries,” said Sadiq Panjwani, General Manager at Teledyne FLIR IIS. “Unlike general-purpose cameras in a crowded machine vision market, our solution is tailored to address the complexities of a specific industry. We focus on key markets, and develop solutions from the ground up, armed with a clear understanding of the market, customer partnerships,
RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF TULIKIVI CORPORATION25.4.2024 17:00:00 CEST | Press release
TULIKIVI CORPORATION STOCK EXCHANGE RELEASE 25 APRIL 2024 AT 18:00 EEST The Annual General Meeting of Tulikivi Corporation was held on 25 April 2024 in Helsinki. The Annual General Meeting approved the financial statements for the financial year 2024 and discharged the members of the Board and the Managing Director from liability. The Annual General Meeting accepted the proposals of the Board to authorise the board to decide on the issue of new shares or the company’s own shares in possession of the company and on the right to issue rights of option and other special rights entitling to shares. The Annual General Meeting approved Tulikivi Corporation’s Remuneration Policy and Remuneration Report for Governing Bodies. The resolutions on the Remuneration Policy and Remuneration Report are advisory. Dividend The Annual General Meeting approved the Board of Directors’ proposal that EUR 0.01/share be paid on A shares and EUR 0.0083/share be paid on K shares and that the remainder of the dis
Northern Horizon Capital AS 2023 Annual Report25.4.2024 16:55:00 CEST | Press release
The general meeting of shareholders of Northern Horizon Capital AS, the management company of Baltic Horizon Fund, has approved the management company’s audited annual report of year 2023. The report, together with the independent auditors’ report is available on the Baltic Horizon Fund webpage. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS. Both the Fund and the Management Company are supervised by the Estonian Financial Supervision Authority. Distribution: Nasdaq, GlobeNewswire, www.baltichorizon.com To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also follow Baltic Horizon Fund on www.baltichorizon.com and on LinkedIn, Facebo